We go back to the 1950s to find out how one of our scientists helped transform the outlook for women with a rare cancer called choriocarcinoma.
In part 4 of our radiotherapy series we look at MRI-guided radiotherapy, and how it could help improve accuracy and reduce side effects.
When she was four, Alyssa was diagnosed with cancer. Here, she and her mom Angela tell her story.
Read Alfred’s story of joining the STAMPEDE clinical trial. His is one of the many stories featured in our 2016/17 Annual Review.
In part 2 of our new radiotherapy series, we discuss proton beam therapy. What can and can’t it offer? And what does its arrival in the UK mean for patients?
Today we’re launching a brand new series on radiotherapy. In this instalment, find out about the treatment’s fascinating history and how it works.
New research by our scientists may have identified a new way to predict which patients might benefit from certain immunotherapies, and those who likely won’t.
Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.